HPV Vaccine Injury and Death Claims Paid: Revealed by Judicial Watch

March 28, 2013 By Leave a Comment
HPV vaccine controversy

[SaneVax: Judicial Watch recently reported the results of their latest Freedom of Information Act request - How much has the Vaccine Injury Compensation Program paid out in claims for injuries or death after HPV vaccination?] Feds pay millions due to deadly HPV shot By Garth Kent, WND [excerpt] The public interest law firm Judicial Watch filed a [...]

[Continue reading...]
Filed Under: HPV, United States, Vaccine Injury Compensation Program Tagged With: , ,

HPV vaccines receive cool reception in India

August 21, 2012 By Leave a Comment
2 shots as good as 3?

[SaneVax:  Doctors in India appear to have many questions about HPV vaccine safety, efficacy and need. The lack of official government response to their questions has apparently led to a free-for-all situation with some refusing to administer Gardasil or Cervarix and others telling their patients it is mandatory.] Docs advise caution on cancer vaccine By Prithvijit [...]

[Continue reading...]
Filed Under: HPV, India Tagged With: , , ,

Shaw and Tomljenovich: Estimates of HPV Vaccine Safety and Efficacy

August 1, 2012 By Leave a Comment
2 shots as good as 3?

[SaneVax:  Christopher Shaw and Lucija Tomljenovic have once again hit the nail on the head when it comes to revealing the truth behind HPV vaccination policies and practices. In a recent letter to the editor of the  American Journal of  Public Health, they disclose that when comparing the adverse events reported after Gardasil to all other vaccines [...]

[Continue reading...]
Filed Under: Gardasil / Silgard, Vaccine Marketing, Vaccine Science, World News Tagged With: , ,

New Study: HPV Vaccine and Evidence of Herd Immunity or Type Replacement?

July 18, 2012 By 16 Comments
Sanevax-square

By Norma Erickson, President Medical professionals rely on studies published in medical journals to keep abreast of new developments in their field. What happens when published studies raise more questions than answers? Where does that leave trusting medical consumers? On July 12, 2012, Australia became the first country in the world to formally offer taxpayer [...]

[Continue reading...]
Filed Under: Gardasil / Silgard, HPV Science, SANE Vax Press Releases, World News Tagged With: , ,

Perhaps HPV Vaccination Sanity Exists After All

June 25, 2012 By Leave a Comment
2 shots as good as 3?

[SaneVax: Governor of South Carolina, Nikki Haley, is still facing criticism for exercising her power of veto last week on a proposed HPV vaccine bill.  Considering all of  the controversy surrounding the safety, affordability, need and efficacy of HPV vaccines, one has to wonder why all government officials are not taking the same stance. Why [...]

[Continue reading...]
Filed Under: HPV, United States, Vaccine Politics/People Tagged With: , ,

Path’s HPV Trials in India: Troubling Questions

June 24, 2012 By Leave a Comment
Vaccine Science

[SaneVax: The questions Professor Allyson Pollock discusses with Newsclick regarding the Path sponsored Human Pappilomavirus Vaccine trials in Gujarat and Andhra Pradesh are the same questions every government in the world should be asking. She brings up many troubling issues raised by such trials, not just the more controversial one surrounding the lack of informed consent. [...]

[Continue reading...]
Filed Under: Pharma Videos Tagged With: , , ,

PATH and HPV Vaccines in India: The clinical trials that should not have been

June 22, 2012 By 1 Comment
Informed Consent?

[SaneVax:  Why attempt to establish an HPV vaccination program where the epidemiological evidence does not support the need? Why attempt to establish a vaccination program where there is no adequate surveillance system in place to monitor efficacy? Why attempt to establish a vaccination program with the most expensive vaccine on the market in a country [...]

[Continue reading...]
Filed Under: Clinical Trials, HPV, India Tagged With: , ,

Incident HPV 51 Infection After Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine Gardasil/Silgard®

May 3, 2012 By Leave a Comment

Philippe Halfon,1,2 Sophie Ravet,3 Hacène Khiri,1 Guillaume Penaranda,1,2,3 and Carole Lefoll2 1 Laboratoire Alphabio, Marseille, France 2 Hopital Ambroise Paré, Marseille, France 3 CDL Pharma, Marseille, France Corresponding author email: philippe.halfon@alphabio.fr This is an open access article. Unrestricted non-commercial use is permitted provided the original work is properly cited. Abstract We report the case of a 19-year-old woman who received a complete vaccine [...]

[Continue reading...]
Filed Under: Gardasil/Silgard Vaccine, Human Papillomavirus Research Tagged With: , ,

New Price Commitment: HPV Vaccine to GAVI for US $5 per Dose

April 12, 2012 By 1 Comment

[SaneVax: No one wants to impede the progress toward potential elimination of cancer. However, this article brings up multiple questions. Why are HPV vaccines being introduced in countries where there is limited or no access to health facilities capable of providing the cancer screening which is still required post-vaccination? Why were HPV vaccines introduced in countries [...]

[Continue reading...]
Filed Under: Cervarix, Gardasil / Silgard, World News Tagged With: , ,

VAERS HPV Vaccine Adverse Injury Reports through February 13, 2012

March 18, 2012 By 6 Comments

Vaccine Adverse Event Reporting System VAERS HPV 4 Gardasil & HPV 2 Cervarix Data collected by HPV Vaccine Research Analyst, Janny Stokvis    

[Continue reading...]
Filed Under: United States, Vaccine Adverse Events, VAERS Tagged With: , , , , , , , , ,